简体
  • 简体中文
  • 繁体中文
×

热门资讯> 正文

双子治疗公司(纳斯达克代码：GMTX)股价下跌5.2%

2022-07-06 13:40

Gemini Therapeutics, Inc. (NASDAQ:GMTX – Get Rating)'s share price was down 5.2% on Tuesday . The stock traded as low as $1.62 and last traded at $1.63. Approximately 45,507 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 251,995 shares. The stock had previously closed at $1.72.

双子座治疗公司(Gemini Treateutics，Inc.)股价周二下跌5.2%，盘中一度跌至1.62美元，最新报1.63美元。午盘，约有45,507股股票易手，较251,995股的日均成交量下跌82%。此前该股收盘价为1.72美元。

Separately, HC Wainwright cut Gemini Therapeutics from a "buy" rating to a "neutral" rating and dropped their price target for the company from $5.00 to $2.00 in a research report on Friday, March 11th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $6.90.

另外，在3月11日星期五的一份研究报告中，HC Wainwright将双子座治疗公司的评级从“买入”下调至“中性”，并将该公司的目标价从5.00美元下调至2.00美元。三位研究分析师对该股的评级为持有，两位分析师对该公司股票的评级为买入。根据MarketBeat.com的数据，该股目前的共识评级为持有，共识目标价为6.90美元。

Get
到达
Gemini Therapeutics
双子座治疗公司
alerts:
警报：

The stock has a market cap of $70.46 million, a price-to-earnings ratio of -1.04 and a beta of -0.06. The company has a 50-day moving average of $1.47 and a 200-day moving average of $1.70.

该股市值为7,046万美元，市盈率为-1.04，贝塔系数为-0.06。该公司的50日移动均线切入位在1.47美元，200日移动均线切入位在1.70美元。

Gemini Therapeutics (NASDAQ:GMTX – Get Rating) last issued its quarterly earnings results on Friday, May 6th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.15). Analysts predict that Gemini Therapeutics, Inc. will post -0.6 earnings per share for the current fiscal year.
双子座治疗公司(纳斯达克代码：GMTX-GET评级)最近一次发布季度收益报告是在5月6日星期五。该公司公布该季度每股收益(EPS)为0.35美元，低于普遍预期的0.20美元和0.15美元。分析师预测，双子座治疗公司将公布本财年每股收益为0.6美元。

In related news, major shareholder Braden Michael Leonard purchased 504,487 shares of the company's stock in a transaction that occurred on Monday, April 11th. The shares were purchased at an average price of $1.35 per share, for a total transaction of $681,057.45. Following the transaction, the insider now directly owns 4,604,487 shares of the company's stock, valued at approximately $6,216,057.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 12.90% of the company's stock.

在相关新闻中，大股东Braden Michael Leonard在4月11日星期一的交易中购买了504,487股该公司股票。这些股票是以每股1.35美元的平均价格购买的，总交易额为681,057.45美元。交易完成后，这位内部人士现在直接持有该公司4,604,487股股票，价值约6,216,057.45美元。这笔交易是在提交给美国证券交易委员会(Securities&Exchange Commission)的一份文件中披露的，可以通过这个超级链接访问。内部人士持有该公司12.90%的股份。

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Allspring Global Investments Holdings LLC acquired a new position in Gemini Therapeutics during the 4th quarter worth approximately $47,000. Marquette Asset Management LLC purchased a new position in shares of Gemini Therapeutics during the 1st quarter worth $92,000. Renaissance Technologies LLC lifted its stake in shares of Gemini Therapeutics by 2,850.4% during the 1st quarter. Renaissance Technologies LLC now owns 351,100 shares of the company's stock worth $488,000 after purchasing an additional 339,200 shares during the period. BlackRock Inc. raised its position in shares of Gemini Therapeutics by 3.5% in the 1st quarter. BlackRock Inc. now owns 1,300,204 shares of the company's stock worth $1,807,000 after buying an additional 43,831 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of Gemini Therapeutics by 4.3% in the 3rd quarter. Geode Capital Management LLC now owns 473,735 shares of the company's stock worth $1,913,000 after buying an additional 19,540 shares during the period. Institutional investors own 74.65% of the company's stock.

对冲基金和其他机构投资者最近增持或减持了该业务的股份。AllSpring Global Investments Holdings LLC在第四季度收购了Gemini治疗公司的一个新头寸，价值约4.7万美元。Marquette Asset Management LLC在第一季度购买了价值92,000美元的双子治疗公司新股票头寸。复兴科技有限责任公司在第一季度增持了双子座治疗公司2850.4%的股份。复兴科技有限责任公司现在拥有351,100股该公司的股票，价值488,000美元，在此期间又购买了339,200股。贝莱德股份有限公司在第一季度将其在双子座治疗公司的股票持仓量提高了3.5%。贝莱德股份有限公司在此期间增持了43,831股，目前持有1,300,204股该公司股票，价值1,807,000美元。最后，Geode Capital Management LLC在第三季度将其在双子座治疗公司的股票头寸提高了4.3%。Geode Capital Management LLC现在持有该公司473,735股股票，价值1,913,000美元，在此期间又购买了19,540股。机构投资者持有该公司74.65%的股票。

Gemini Therapeutics Company Profile (NASDAQ:GMTX)

双子座治疗公司简介(纳斯达克：格林尼治标准时间)

Gemini Therapeutics, Inc, a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients.

Gemini治疗公司是一家临床阶段精准药物公司，致力于开发各种治疗化合物，用于治疗遗传定义的年龄相关性黄斑变性(AMD)。它的主要候选药物是GEM103，一种重组形式的人类补体因子H蛋白，用于治疗干性AMD患者。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on Gemini Therapeutics (GMTX)
  • 3 Education Stocks to Enroll in This Summer
  • The Institutions Get Comfortable With The Lovesac Company
  • McDonald's Might Just Be The Best Recession Proof Stock
  • Basset Furniture Quietly Proves Its Value
  • Earnings Revisions: Why You Shouldn't Count On A Rebound In Stocks ... Yet
  • 免费获取StockNews.com关于双子座治疗(GMTX)的研究报告
  • 3只教育类股将于今夏入围
  • 这些机构对Lovesac公司感到满意
  • 麦当劳可能就是最好的抗衰退股票
  • Basset家具悄然证明其价值
  • 收益修正：为什么你不应该指望股市反弹。还没有

Receive News & Ratings for Gemini Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gemini Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

接受《双子座治疗日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对双子座治疗公司和相关公司的最新新闻和分析师评级的每日简要摘要。

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
问答大全
（工作日09：30 - 次日05：30）
客户端：
关注我们：
  • 微信公众号二维码

© 2025 深圳市时代华盛网络科技有限公司版权所有 粤ICP备16068286号